Massachusetts Financial Services Co. MA Has $622.86 Million Position in Intuitive Surgical, Inc. $ISRG

Massachusetts Financial Services Co. MA lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,146,204 shares of the medical equipment provider’s stock after selling 18,674 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Intuitive Surgical were worth $622,859,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Tobam grew its stake in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the period. TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares in the last quarter. 1248 Management LLC bought a new stake in Intuitive Surgical in the first quarter valued at $30,000. Princeton Global Asset Management LLC acquired a new position in Intuitive Surgical during the second quarter worth $30,000. Finally, Bank of Jackson Hole Trust lifted its holdings in shares of Intuitive Surgical by 70.5% during the first quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 31 shares during the period. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. This trade represents a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $560.00, for a total transaction of $58,800.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 116,164 shares of company stock worth $61,916,172 over the last ninety days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $549.51 on Friday. The stock has a market cap of $196.99 billion, a price-to-earnings ratio of 72.69, a P/E/G ratio of 4.94 and a beta of 1.62. The company has a 50 day moving average of $482.51 and a 200-day moving average of $503.09. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. The firm’s revenue was up 22.9% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Argus boosted their target price on Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Finally, Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.